LETTER TO THE EDITOR
Third dose of coronavirus disease 2019 vaccination in liver transplantation recipients
Won Sriwijitalai,
Corresponding Author
Won Sriwijitalai
Private Academic Consultant, Dimapur, India
Correspondence
Won Sriwijitalai, Private Academic Consultant, Dimapur, India.
Email: [email protected]
Search for more papers by this author Viroj Wiwanitkit,
Viroj Wiwanitkit
Department of Community Medicine, Dr DY Patil University, Pune, India
Search for more papers by this author
Won Sriwijitalai,
Corresponding Author
Won Sriwijitalai
Private Academic Consultant, Dimapur, India
Correspondence
Won Sriwijitalai, Private Academic Consultant, Dimapur, India.
Email: [email protected]
Search for more papers by this author Viroj Wiwanitkit,
Viroj Wiwanitkit
Department of Community Medicine, Dr DY Patil University, Pune, India
Search for more papers by this author
First published: 22 April 2022
No abstract is available for this article.
REFERENCE
- 1Strauss AT, Chang A, Alejo JL, Chiang TP, Hernandez NF, Zeiser LB, et al. Severe acute respiratory syndrome coronavirus 2 antibody response to a third dose of homologous messenger RNA vaccination in liver transplantation recipients. Liver Transpl. 2022; 28: 1393–96.